A healthcare focused fund is headquartered in Shanghai and has presence in US and Europe. The fund has strong preference for early stage opportunities. The senior team members have strong operating experience in biotech and pharma companies, the firm has a strong preference to lead investments and play active contribute to the success in our portfolio companies.
The firm is particularly keen on cardiovascular, regenerative medicine, CNS and hearing related opportunities. The firm is otherwise agnostic in regards to specific disease indications and is willing to look at all early-stage opportunities, however, diagnostics is currently considered as a low priority.
As the firm seeks to be an active lead investor, the firm strongly prefers a board seat in companies. Outside of the board requirement, the firm is looking for a strong management team with passion and capability in advancing the company’s technology.
If you are interested in more information about this investor and other investors tracked by LSN, please email RESI@lifesciencenation.com.
Leave a Reply